Similar articles

• Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates.

  Mosesson MW, Finlayson JS, Umfleet RA, Galanakis D. Mosesson MW, et al. J Biol Chem. 1972 Aug 25;247(16):5210-9. J Biol Chem. 1972. PMID: 4262568 No abstract available.
• C-phycocyanin from Phormidium luridum. Isolation of subunits.

  Kobayashi Y, Siegelman HW, Hirs CH. Kobayashi Y, et al. Arch Biochem Biophys. 1972 Sep;152(1):187-98. doi: 10.1016/0003-9861(72)90207-x. Arch Biochem Biophys. 1972. PMID: 4627355 No abstract available.
• Activation of platelet fibrin-stabilizing factor by thrombin.

  Hung GW, Sonnichsen WJ, James HL, Ganguly P. Hung GW, et al. Biochim Biophys Acta. 1974 Dec 18;371(2):511-8. doi: 10.1016/0005-2795(74)90047-6. Biochim Biophys Acta. 1974. PMID: 4215455 No abstract available.
• Degradation of fibrinogen by plasmin: physicochemical characteristics and their correlation to antithrombic activity.

  Triantaphyllopoulos E. Triantaphyllopoulos E. Thromb Diath Haemorrh Suppl. 1973;56:91-112. Thromb Diath Haemorrh Suppl. 1973. PMID: 4281941 Review. No abstract available.
• Cross-linking of fibrin by fibrin=stabilizing factor.

  McKee PA, Schwartz ML, Pizzo SV, Hill RL. McKee PA, et al. Ann N Y Acad Sci. 1972 Dec 8;202:127-48. doi: 10.1111/j.1749-6632.1972.tb16326.x. Ann N Y Acad Sci. 1972. PMID: 4565368 Review. No abstract available.